| dc.contributor.author | Kilickap, S. | |
| dc.contributor.author | Arslan, C. | |
| dc.date.accessioned | 2019-07-27T12:10:23Z | |
| dc.date.accessioned | 2019-07-28T10:13:45Z | |
| dc.date.available | 2019-07-27T12:10:23Z | |
| dc.date.available | 2019-07-28T10:13:45Z | |
| dc.date.issued | 2010 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.uri | https://dx.doi.org/10.1093/annonc/mdq011 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12418/9904 | |
| dc.description | WOS: 000276045600037 | en_US |
| dc.description | PubMed ID: 20139155 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | OXFORD UNIV PRESS | en_US |
| dc.relation.isversionof | 10.1093/annonc/mdq011 | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true? | en_US |
| dc.type | letter | en_US |
| dc.relation.journal | ANNALS OF ONCOLOGY | en_US |
| dc.contributor.department | [Kilickap, S.] Cumhuriyet Univ, Fac Med, Dept Internal Med, Div Med Oncol, Sivas, Turkey -- [Arslan, C.] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey | en_US |
| dc.contributor.authorID | Aksoy, Sercan -- 0000-0003-4984-1049; Arslan, Cagatay -- 0000-0002-3783-7432 | en_US |
| dc.identifier.volume | 21 | en_US |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.endpage | U237 | en_US |
| dc.identifier.startpage | 902 | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
